MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress

High Growth Tech Stocks to Watch in October 2024

MeiraGTx’s Parkinson’s gene therapy shows promise in Phase I/II study

MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study

MeiraGTx Holdings Reports Promising Parkinson’s Therapy Results

MeiraGTx (MGTX) Surges 14.9%: Is This an Indication of Further Gains?

Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy Endpoints

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease

MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference

MeiraGTx Holdings plc's (NASDAQ:MGTX) Profit Outlook

Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains?

Exploring Three High Growth Tech Stocks in the United States